Anthem to Cover C2N Diagnostics’ PrecivityAD2® Blood Test, Expanding Access to Alzheimer’s Disease Diagnostics Beginning October 2026 C2N Diagnostics, LLC, a specialty diagnostics company focused on advancing precision medicine through innovative diagnostic technologies, has announced a significant milestone in Alzheimer’s…
LEO Pharma Reports Positive Phase 2 TRAPEDS-1 Results for Tralokinumab in Children with Moderate-to-Severe Atopic Dermatitis LEO Pharma A/S, a global company specializing in medical dermatology, has announced positive topline results from its Phase 2 TRAPEDS-1 clinical trial, which evaluated…
Retham Technologies Launches Next-Generation Cryoplatelets to Improve Platelet Research and Laboratory Testing Retham Technologies, Inc. has announced the commercial launch of Retham Cryoplatelets™, a next-generation functional platelet product developed to address one of the most persistent challenges in biomedical research—the…
Randomized Trial Highlights Ketogenic Diet Benefits in Psychotic Disorders A new clinical study published in Schizophrenia Bulletin has provided encouraging evidence that a ketogenic diet may offer meaningful benefits for individuals living with serious mental illnesses such as schizophrenia-spectrum disorders…
Niagen Bioscience Launches NB4168 Pharmaceutical Program Targeting Rare Genetic Diseases and Accelerated Aging Niagen Bioscience expands its leadership in NAD+ science into pharmaceutical development with NB4168, an investigational oral therapy designed for Ataxia Telangiectasia and other DNA repair disorders. Niagen…
Agilent Expands Altura HPLC Portfolio with New SEC and PLRP-S Columns to Advance Biopharmaceutical Analysis Agilent Technologies Inc. has expanded its Altura high-performance liquid chromatography (HPLC) column portfolio with the launch of Altura Size Exclusion Chromatography (SEC) and Altura PLRP-S…
Spear Bio to Showcase Next-Generation Alzheimer’s Biomarker Technologies and Automated SPEAR Platform at AAIC 2026 Spear Bio, a biotechnology company specializing in ultrasensitive protein biomarker detection technologies, has announced that it will introduce several major additions to its biomarker research…
Bayer Forms Strategic Clinical Trials Alliance with University of Colorado Anschutz, UCHealth, and Children’s Hospital Colorado to Accelerate Medical Innovation Bayer has announced the formation of a landmark strategic alliance with the University of Colorado Anschutz Medical Campus (CU Anschutz),…
Ionis Pharmaceuticals Completes Enrollment in Pivotal Phase 3 REVEAL Study Cohort Evaluating Obudanersen for Angelman Syndrome Ionis Pharmaceuticals, Inc. has announced the completion of enrollment in the pivotal pediatric cohort of its global Phase 3 REVEAL clinical trial evaluating obudanersen…
Immunomic Therapeutics Doses First Participant in Phase 1 Trial of ITI-9001 Therapeutic Vaccine for Japanese Cedar Pollen Allergy Immunomic Therapeutics Inc. (ITI), a clinical-stage biotechnology company and subsidiary of HLB, has announced the dosing of the first participant in its…
Visby Medical Receives FDA Clearance for First At-Home Multi-Viral PCR Test for COVID-19 and Influenza Visby Medical, a company focused on developing rapid molecular diagnostics for use at home, has announced that the U.S. Food and Drug Administration (FDA) has…
Medical University of Graz Enrolls First Patient in DEEPER CHALLENGE Trial Evaluating Early Vessel Recoil in High-Risk CLTI Patients Reflow Medical, Inc. has announced the enrollment of the first participant in the DEEPER CHALLENGE clinical trial, marking an important milestone…